All In Biotech

Free tool

FAERS Monitor: Sodium Thiosulfate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203923 or its brand name (Sodium Thiosulfate, Sodium Thiosulfate). Reports on generic versions are filed under their own applications.

Reports

490

Serious

444

91% of reports

Hospitalization

187

Death reported

80

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use107
  • calciphylaxis89
  • drug ineffective57
  • nausea38
  • metabolic acidosis31
  • sepsis23
  • vomiting22
  • condition aggravated21
  • death18
  • pruritus17
  • erythema16
  • pain16
  • calcinosis13
  • hypocalcaemia12
  • pyrexia12

Reports by year received

View as table
YearReports
20054
20062
20073
20082
20096
20107
201119
20123
201311
201412
201514
201615
201732
201823
201929
202038
202145
202243
202341
202469
202527
202644

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,669 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
calciphylaxisSignal892188.91803.4183,140
calcinosisSignal13251.3146.72,978
metabolic acidosisSignal3141.729.61,190
hypocalcaemiaSignal1227.215.6278
sepsisSignal238.95.9153
off label useSignal1075.24.4379
erythemaSignal163.32.124
condition aggravatedSignal213.02.026
nauseaSignal382.11.520
vomitingSignal222.01.310
pruritus171.91.26
drug ineffective571.91.523
pyrexia121.50.91
pain161.10.70
death180.90.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.